In Vitro Antibacterial Activity of WCK 5999: A New Carbapenem/β-lactamase Inhibitor Combination against ESBL-Phenotype and Carbapenemase Producing Enterobacteriaceae from a Worldwide Surveillance Program (2015)
In Vitro Antibacterial Activity of WCK 5999: A New Carbapenem/β-lactamase Inhibitor Combination against ESBL-Phenotype and Carbapenemase Producing Enterobacteriaceae from a Worldwide Surveillance Program (2015), Lead author: Huband M, presented at 1st annual American Society for Microbiology General Meeting (MICROBE), June 16 – 20, 2016, Boston, Massachusetts, USA
Monday-425
